Skip to content

Drug interactions

Cladribine + Danicopan

Severity: Moderate

Cladribine and Danicopan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Danicopan inhibits BCRP, and cladribine absorption and disposition depend on BCRP. Cladribine exposure may therefore increase, raising the risk of hematologic toxicity.

What this interaction means in plain words

Cladribine and Danicopan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Cladribine belongs to Oncology; Danicopan belongs to Miscellaneous.

Evidence level: Moderate

Why it happens

Inhibition of the BCRP efflux transporter by danicopan increases cladribine bioavailability.

What to do

Avoid coadministration if possible, or monitor blood counts and lymphocyte counts closely. Consider cladribine dose reduction per labeling.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cladribine and Danicopan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Cladribine with Danicopan?

MediHelp rates the interaction as moderate. Cladribine and Danicopan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Danicopan inhibits BCRP, and cladribine absorption and disposition depend on BCRP. Cladribine exposure may therefore increase, raising the risk of hematologic toxicity.

How serious is the interaction between Cladribine and Danicopan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid coadministration if possible, or monitor blood counts and lymphocyte counts closely. Consider cladribine dose reduction per labeling.

What other medicines interact with Cladribine?

MediHelp also lists interactions of Cladribine with, for example, Adenovirus types 4 and 7 live, Siponimod, Tofacitinib. The full list is on the Cladribine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in